Search Results 1191-1200 of 18000 for sickle cell
The purpose of this study is to provide access to CTL019 through Managed Access Program (MAP) for acute lymphoblastic leukemia (ALL) or diffuse large b-cell ...
Their findings are published online this month in the Journal of Cell Science. cells. The study found that in anaplastic thyroid cancer, the Forkhead ...
The purpose of this study is to perform RNA sequencing on induced pluripotent stem cells (iPSC). By comparing the gene expression of motor neurons derived from ...
10 Mayo Clinic research advances in 2024, spanning stem cell therapy in space to growing mini-organs.
In general terms, scientists will study the cells, DNA, RNA, and proteins found in the tumor tissue and/or the blood to understand more about cancer and the ...
ROCHESTER, Minn. — Mayo Clinic researchers have uncovered how aging "zombie cells" trigger harmful inflammation that accelerates a severe and increasingly ...
Durvalumab is FDA approved for treatment in lung cancers including non-small cell lung cancer and small cell lung cancer. Venetoclax is FDA approved for the ...
This clinical study further documented lower death and hospitalization rates among those treated with cell therapy. This research is published in Stem Cells ...
Abemaciclib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib is an inhibitor of PARP, an enzyme that ...
Science Saturday: Addressing the challenges of chimeric antigen receptor-T cell therapy featured image ... Preeclampsia linked to increased markers of brain cell ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.